This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fawer, R. Articles by Schelling, J. L. Search for Related Content PubMed PubMed Citation Articles by Fawer, R. Articles by Schelling, J. L.

Stroke, Vol 9, 484-486, Copyright © 1978 by American Heart Association

ARTICLES

Intravenous glycerol in cerebral infarction: a controlled 4-month trial

R Fawer, JC Justafre, JP Berger and JL Schelling

A double-blind, randomized trial was performed with 51 patients suffering from focal ischemic lesions in the territory of the middle cerebral artery. Intravenous infusions of 10% glycerol in 0.9% NaCl--5% glucose solutions were administered twice daily for 6 days to 26 patients, and the same amount of NaCl--glucose solutions to 25 controls. Glycerol did not reduce mortality (9 deaths in each group). The functional recovery was assessed by repeated neurological examinations during the 4 month trial. Glycerol significantly improved global performances and motor and sensory functions in patients with moderate disability, but its effect on global performances was transient. The patients with severe disability were not improved at all.

This article has been cited by other articles:

				F. Gotoh, Y. Terayama, and T. Amano Development of a Novel, Weighted, Quantifiable Stroke Scale: Japan Stroke Scale Stroke, August 1, 2001; 32(8): 1800 - 1807. [Abstract] [Full Text] [PDF]